Toggle navigation
About
Company Overview
Partners and Distributors
Our People
Scientific Advisory Board
Corporate Directory
Corporate Governance
Approved Products
Manufacturing Facilities
Bronchitol®
Cystic Fibrosis
Clinical Trials
Publications
Patents
Partners and Distributors
Aridol®
Asthma
Clinical Trials
Publications
Patents
Distributors
Product Pipeline
Drug Discovery
Facilities & Capabilities
Publications & Posters
Patents
Amine Oxidase Platform
SSAO Inhibitor BI 1467335
LOXL2 Inhibitors
LOX Systemic Inhibitor
Other Amine Oxidase Inhibitor Programs
Other Pipeline Assets
Orbital® Dry Powder Inhaler
News
Patients & Prescribers
Contact
Media
Follow us
Investor Centre
Investor Centre
News
ASX Announcements
Quarterly Updates
Annual and Half Year Reports
Investor Presentations
Shareholder Services
Upcoming Events
Analyst Coverage
Major Shareholders
Corporate Governance
Subscribe to our Emails
Video Content
Investor Centre
News
News
Appendix 3Y - Dr Villiger
16th
Nov 07
Release Date: 16/11/2007 12:00am
Read full ASX announcement – pdf
Categories:
ASX Announcements
